Amlodipine and Difluprednate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Amlodipine (amlodipine besylate) and Difluprednate (difluprednate). Common drug interactions include blood pressure fluctuation among females and decreased appetite among males.

The phase IV clinical study analyzes what interactions people have when they take Amlodipine and Difluprednate. It is created by eHealthMe based on reports of 79 people who take the same drugs from the FDA, and is updated regularly.

What is Amlodipine?

Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,829 Amlodipine users. Check the latest studies of Amlodipine.

What is Difluprednate?

Difluprednate has active ingredients of difluprednate. eHealthMe is studying from 977 Difluprednate users. Check the latest studies of Difluprednate.



On Jul, 03, 2026

79 people who take Amlodipine and Difluprednate together, and have interactions are studied.

Amlodipine and Difluprednate drug interactions.

What are the common drug interactions of Amlodipine and Difluprednate, by gender? *:

female:

  1. Blood pressure fluctuation
  2. Blood urea increased
  3. Carbon dioxide decreased
  4. Cardiac murmur (an heart sound in valve abnormality)
  5. Chest pain
  6. Cough
  7. Dizziness
  8. Dysuria (painful or difficult urination)
  9. Fluid overload (too much fluid in the blood)
  10. Gangrene (body tissue dies)

male:

  1. Decreased appetite
  2. Pruritus (severe itching of the skin)
  3. Oedema (fluid collection in tissue)
  4. Onychomadesis (a periodic idiopathic shedding of the nails)
  5. Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
  6. Rash
  7. Interstitial lung disease
  8. Cerebral infarction (less blood supply to brain resulting tissue damage)
  9. Constipation
  10. Pneumonitis (inflammation of the walls of the alveoli in the lungs)

What are the common drug interactions of Amlodipine and Difluprednate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anaemia (lack of blood)
  2. Burning sensation
  3. Eye irritation
  4. Ocular hyperaemia (an abnormally large amount of blood in eye)
  5. Rhinalgia (pain in the nose)
  6. Swelling

50-59:

  1. Haematocrit increased
  2. Haemoglobin decreased
  3. Headache (pain in head)
  4. Hypoxia (low oxygen in tissues)
  5. Influenza
  6. International normalised ratio increased
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Metastases to bone (cancer spreads to bone)
  9. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  10. Oropharyngeal pain

60+:

  1. Rash
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Gastric ulcer haemorrhage (bleeding ulcer of stomach)
  4. Nail discolouration (change in nail colour)
  5. Nail ridging (nail has raised ridges and is thin and curved inward)
  6. Oedema (fluid collection in tissue)
  7. Onychomadesis (a periodic idiopathic shedding of the nails)
  8. Oedema peripheral (superficial swelling)
  9. Pneumonia
  10. Cardiac failure

What are the existing conditions these people have? *

  1. Rashes (redness): 15 people, 18.99%
  2. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 13 people, 16.46%
  3. Diarrhea: 13 people, 16.46%
  4. Constipation: 11 people, 13.92%
  5. Insomnia (sleeplessness): 10 people, 12.66%
  6. Hypocalcaemia (levels of calcium in blood serum are abnormally low): 10 people, 12.66%
  7. Colon Cancer: 8 people, 10.13%
  8. Nausea And Vomiting: 7 people, 8.86%
  9. Pain: 6 people, 7.59%
  10. Itching: 6 people, 7.59%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine and Difluprednate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Amlodipine and Difluprednate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Difluprednate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amlodipine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Difluprednate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate and difluprednate (the active ingredients of Amlodipine and Difluprednate, respectively), and Amlodipine and Difluprednate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: